Kittipibul, V., Mentz, R. J., Young, R., Butler, J., Ezekowitz, J. A., Lam, C. S. P., … Armstrong, P. W. (2024). PROJECTING THE BENEFIT OF VERICIGUAT IN POPULATIONS SIMULATED FROM PARADIGM-HF AND DAPA-HF: INSIGHTS FROM THE VICTORIA TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 83, pp. 522–522).

Kittipibul, Veraprapas, Robert John Mentz, Rebecca Young, Javed Butler, Justin A. Ezekowitz, Carolyn S. P. Lam, Piotr Ponikowski, et al. “PROJECTING THE BENEFIT OF VERICIGUAT IN POPULATIONS SIMULATED FROM PARADIGM-HF AND DAPA-HF: INSIGHTS FROM THE VICTORIA TRIAL.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 83:522–522, 2024.

Kittipibul V, Mentz RJ, Young R, Butler J, Ezekowitz JA, Lam CSP, et al. PROJECTING THE BENEFIT OF VERICIGUAT IN POPULATIONS SIMULATED FROM PARADIGM-HF AND DAPA-HF: INSIGHTS FROM THE VICTORIA TRIAL. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024. p. 522–522.

Kittipibul, Veraprapas, et al. “PROJECTING THE BENEFIT OF VERICIGUAT IN POPULATIONS SIMULATED FROM PARADIGM-HF AND DAPA-HF: INSIGHTS FROM THE VICTORIA TRIAL.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 83, no. 13, 2024, pp. 522–522.

Kittipibul V, Mentz RJ, Young R, Butler J, Ezekowitz JA, Lam CSP, Ponikowski P, Voors A, Corda S, McMullan C, O’Connor CM, Anstrom KJ, Armstrong PW. PROJECTING THE BENEFIT OF VERICIGUAT IN POPULATIONS SIMULATED FROM PARADIGM-HF AND DAPA-HF: INSIGHTS FROM THE VICTORIA TRIAL. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024. p. 522–522.